Showing results (1191-1200 of 1,240) with videos related to
Sort By:
Pageof 124
The Lancet. Oncology|November 17, 2018
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, et al.Physical Review Letters|March 17, 2011
High-precision half-life measurement for the superallowed β+ emitter ²⁶Al(m)P Finlay, S Ettenauer, G C Ball, et al.European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.Ophthalmology|June 17, 2022
Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy TrialTomas S Aleman, Rachel M Huckfeldt, Leona W Serrano, et al.The Canadian Journal of Cardiology|January 29, 2013
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adultTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.Physical Review Letters|June 4, 2008
Internal gamma decay and the superallowed branching ratio for the beta(+) emitter (38)K(m)K G Leach, C E Svensson, G C Ball, et al.Cell Metabolism|December 6, 2024
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in miceXinxin Yu, Shiuhwei Chen, Jan-Bernd Funcke, et al.Science Immunology|April 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunityTianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.The Lancet. Oncology|March 6, 2017
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Andrew D J Pearson, et al.NPJ Aging and Mechanisms of Disease|July 20, 2017
Cytochrome b reductase and the control of lipid metabolism and healthspanAlejandro Martin-Montalvo, Yaning Sun, Alberto Diaz-Ruiz, et al.Pageof 124